COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 493: Articles 4921-4930  | Next

Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
Cunha, J. B., Leix, K., Sherman, E. J., Mirabelli, C., Kennedy, A. A., Lauring, A. S., Tai, A. W., Wobus, C. E., Emmer, B. T.
10.1101/2023.02.28.530557 — Posted: 2023-03-01
COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
Fryer, H. A., Hartley, G. E., Edwards, E. S. J., Varese, N., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O'Hehir, R. E., van Zelm, M. C.
10.1101/2023.02.28.530547 — Posted: 2023-03-01
IgG4 serum levels are not elevated in cases of Post-COVID syndrome
Abel, J., Walter, A. J., Glueck, V., Magnus, C. L., Glueck, T., Schuster, P., Blaas, S., Montanari, I., Koller, M., Mohr, A., Hinterberger, T., Salzberger, B., Renner, K., Mack, M., Bals, R., Schmidt, T., Klemis, V., Sester, M., Kardashi, R., de With, K., Loew, T. H., Malfertheiner, M., Pfeifer, M., Gessner, A., Schmidt, B., Schmalenberger, D., Peterhoff, D.
10.1101/2023.03.01.530454 — Posted: 2023-03-01
SARS-CoV-2 ORF3c suppresses immune activation by inhibiting innate sensing
Mueller, M., Herrmann, A., Fujita, S., Kolberg, E. J., Kruth, C., Stange, A., Schneider, M., Ito, J., Ensser, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K., Sauter, D.
10.1101/2023.02.27.530232 — Posted: 2023-03-01
Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients - An observational study of five cohorts across four countries
Lovik, A., Gonzalez-Hijon, J., Hoffart, A., Fawns-Ritchie, C., Magnusdottir, I., Lu, L., Unnarsdottir, A. B., Kähler, A. K., Campbell, A., Hauksdottir, A., Chourpiliadis, C., McCartney, D. L., Thordardottir, E. B., Joyce, E. E., Frans, E. M., Jakobsdottir, J., Trogstad, L., Andreassen, O. A., Magnus, P., Johnson, S. U., Sullivan, P. F., Aspelund, T., Porteous, D. J., Ask, H., Ebrahimi, O. V., Valdimarsdottir, U. A., Fang, F.
10.1101/2023.02.28.23286559 — Posted: 2023-03-01
Mixed methods approach to examining the implementation experience of a phone-based health research survey investigating risk factors for SARS-CoV-2 infection in California
Fukui, N., Li, S. S., DeGuzman, J., Myers, J., Openshaw, J., Sharma, A., Watt, J., Lewnard, J., Jain, S., Andrejko, K., Pry, J. M.
10.1101/2023.02.27.23286454 — Posted: 2023-03-01
Combining models to generate a consensus effective reproduction number R for the COVID-19 epidemic status in England
Park, J., Bevan, L., Sanchez-Marroquin, A., Danelian, G., Bayley, T., Manley, H., Bowman, V., Maishman, T., Finnie, T., Charlett, A., Nowcasts Models Contribution Group, , Watkins, N. A., Hutchinson, J., Riley, S., Panovska-Griffiths, J.
10.1101/2023.02.27.23286501 — Posted: 2023-03-01
The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
Stoddard, M., Yuan, L., Sarkar, S., Van Egeren, D., White, L., Chakravarty, A.
10.1101/2023.02.26.23286471 — Posted: 2023-03-01
Maternal Characteristics and Pregnancy Outcomes During The Pandemic Covid-19 in Indonesian Tertiary Referral Hospital
Farizi, S. A., Setyowati, D. A., Dyah, F. A., Azyanti, A. F., Rahayu, C. K.
10.1101/2023.02.27.23286514 — Posted: 2023-03-01
A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China
Yao, Y., Yang, Y., Wu, Q., Liu, M., Bao, W., Wang, Q., Cheng, M., Chen, Y., Cai, Y., Zhang, M., Yao, J., He, H., Jin, C., Xue, T., Zheng, C., Jin, T., Tong, D.
10.1101/2023.02.28.23286535 — Posted: 2023-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).